Implementation of EU risk minimisation measures for medicinal products in clinical guidelines

For more information on this project, please contact the EU PE&PV research network at eupepv@uu.nl.

Project information

  • EU PE&PV research network
  • EUPAS47588
  • Specific Contract 01 implementing Framework service contract EMA/2020/46/TDA/L4.02 

Full title

Implementation of EU risk minimisation measures for medicinal products in clinical guidelines 

Principal investigator

Prof. Dr. Helga Gardarsdottir, Utrecht University

Participating organisations

  • Utrecht University, The Netherlands - co-lead, consortium lead
  • University of Copenhagen, Denmark - co-lead
  • Democritus University of Thrace, Greece
  • Rīga Stradiņš University, Latvia
  • RIVM, The Netherlands
  • UMC Utrecht, The Netherlands
  • University of Porto, Portugal
  • University of Ljubljana, Slovenia 

Status

Completed (2023)

Deliverables

 

Peer-reviewed scientific publications